Trial Profile
A proof of concept study investigating the uptake of radiolabeled 99mTc-certolizumab pegol in patients with erosive hand osteoarthritis to relate to disease activity and structural progression
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Sep 2016
Price :
$35
*
At a glance
- Drugs Certolizumab pegol (Primary)
- Indications Osteoarthritis
- Focus Diagnostic use; Proof of concept
- 29 Sep 2016 New trial record